Oncorus, Inc.
Oncolytic viral delivery of therapeutic polypeptides

Last updated:

Abstract:

Described herein are pseudotyped oncolytic viruses comprising nucleic acids encoding an engager molecule. In some embodiments, the pseudotyped oncolytic viruses comprises nucleic acids encoding an engager molecule and one or more therapeutic molecules. Pharmaceutical compositions containing the pseudotyped oncolytic virus and methods of treating cancer using the pseudotyped oncolytic viruses are further provided herein.

Status:
Grant
Type:

Utility

Filling date:

25 Oct 2018

Issue date:

31 Mar 2020